Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Structure-function relationships of complement receptor type 1.

M Krych-Goldberg1, J P Atkinson

  • 1Washington University School of Medicine, Rheumatology Division, St Louis, Missouri 63110, USA.

Immunological Reviews
|June 21, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The rare C9 P167S risk variant for age-related macular degeneration increases polymerization of the terminal component of the complement cascade.

Human molecular genetics·2021
Same author

Dysfunction of complement receptors CR3 (CD11b/18) and CR4 (CD11c/18) in pre-eclampsia: a genetic and functional study.

BJOG : an international journal of obstetrics and gynaecology·2021
Same author

Complement regulators in human disease: lessons from modern genetics.

Journal of internal medicine·2014
Same author

Complement receptor structure and function.

Immunology today·2014
Same author

The 20 faces of the fourth component of complement.

Immunology today·2014
Same author

Human C3b- and C4b-regulatory proteins: a new multi-gene family.

Immunology today·2014
Same journal

Diversity, Equality, and Inclusion in the naïve T Cell Receptor Repertoire.

Immunological reviews·2026
Same journal

Macrophage Plasticity and Immune Remodeling in Ischemic Heart Failure.

Immunological reviews·2026
Same journal

The T Cell Receptor: Molecular Sensor, Therapeutic Mediator and Probabilistic Driver of Adaptive Immunity.

Immunological reviews·2026
Same journal

Tissue-Resident Memory T Cells in the Heart: An Emerging Role in Chronic Inflammation.

Immunological reviews·2026
Same journal

Rethinking Immunity in Tissues: The Biology of Tertiary Lymphoid Structures.

Immunological reviews·2026
Same journal

Inflammation-Driven Lymphoid Structures: Organization, Function, and Clinical Impact Across Autoimmunity, Cancer, and Checkpoint Toxicity.

Immunological reviews·2026
See all related articles

Human complement receptor type 1 (CR1) regulates complement activation and immune complex clearance. Structure-function studies reveal how CR1 domains interact with complement fragments, enabling development of potent CR1-derived inhibitors.

Area of Science:

  • Immunology
  • Biochemistry
  • Structural Biology

Background:

  • Human complement receptor type 1 (CR1) is a key regulator of complement activation and immune complex clearance.
  • CR1 belongs to the regulators of complement activation family, characterized by complement control protein repeats (CCPs).
  • Its structure comprises tandem CCP modules that mediate interactions with C3/C4 fragments, crucial for inhibiting complement pathways.

Purpose of the Study:

  • To elucidate the structure-function relationships of CR1 by fine-mapping its active sites.
  • To investigate how variations in CR1 size and copy number in primates affect its function.
  • To identify potential targets for developing novel therapeutic agents that inhibit complement activation.

Main Methods:

  • Analysis of over 100 CR1 derivatives with mutated active sites to map critical sequences and amino acids.

Related Experiment Videos

  • Comparative studies of human CR1 and primate CR1 variants with differing sizes and active site numbers.
  • Structure-function analyses to understand the molecular basis of CR1's inhibitory activities.

    • Main Results:

    • Detailed mapping of CR1's functional sites, identifying critical sequences and amino acids responsible for its activities.
    • Demonstration that increased CR1 copy number compensates for smaller size in primate erythrocytes.
    • Discovery of subtle differences in primate CR1 active sites leading to a broader functional repertoire, ensuring similar biologic activities in shorter forms.

    Conclusions:

    • CR1's structure-function relationships are well-defined, allowing for precise mapping of its inhibitory domains.
    • Primate CR1 variants exhibit adaptations that maintain functional efficacy despite size variations.
    • These findings pave the way for designing smaller, more potent complement inhibitors derived from CR1 for therapeutic applications.